Projects per year
Abstract
Allosteric modulation of adenosine A1 receptors (A1ARs) offers a novel therapeutic approach for the treatment of numerous central and peripheral disorders; however, despite decades of research, there is a relative paucity of structural information regarding the A1AR allosteric site and mechanisms governing cooperativity with orthosteric ligands. We combined alanine-scanning mutagenesis of the A1AR second extracellular loop (ECL2) with radioligand binding and functional interaction assays to quantify effects on allosteric ligand affinity, cooperativity, and efficacy. Docking and molecular dynamics (MD) simulations were performed using an A1AR homology model based on an agonist-bound A2AAR structure. Substitution of E172ECL2 for alanine reduced the affinity of the allosteric modulators PD81723 and VCP171 for the unoccupied A1AR. Residues involved in cooperativity with the orthosteric agonist NECA were different in PD81723 and VCP171; positive cooperativity between PD81723 and NECA was reduced on alanine substitution of a number of ECL2 residues, including E170ECL2 and K173ECL2, whereas mutation of W146ECL2 and W156ECL2 decreased VCP171 cooperativity with NECA. Molecular modeling localized a likely allosteric pocket for both modulators to an extracellular vestibule that overlaps with a region used by orthosteric ligands as they transit into the canonical A1AR orthosteric site. MD simulations confirmed a key interaction between E172ECL2 and both modulators. Bound PD81723 is flanked by another residue, E170ECL2, which forms hydrogen bonds with adjacent K168ECL2 and K173ECL2. Collectively, our data suggest E172ECL2 is a key allosteric ligand-binding determinant, whereas hydrogen-bonding networks within the extracellular vestibule may facilitate the transmission of cooperativity between orthosteric and allosteric sites.
Original language | English |
---|---|
Pages (from-to) | 715-725 |
Number of pages | 11 |
Journal | Molecular Pharmacology |
Volume | 90 |
Issue number | 6 |
DOIs | |
Publication status | Published - 1 Dec 2016 |
Projects
- 8 Finished
-
Adenosine Receptor Biased Agonism to Treat Ischaemic Heart Disease
May, L., Scammells, P., Wang, B. & White, P.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/15 → 31/12/17
Project: Research
-
Understanding mechanisms of allostery and biased agonism at the adenosine A1 receptor
Christopoulos, A., May, L., Scammells, P. & Scott, D.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/15 → 31/12/17
Project: Research